Ignite Creation Date:
2024-05-06 @ 6:49 PM
Last Modification Date:
2024-10-26 @ 2:55 PM
Study NCT ID:
NCT05792813
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-27
First Post:
2023-03-08
Brief Title:
Efficacy and Safety of Linggui Yangyuan Paste in Patients With Male Infertility
Sponsor:
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Organization:
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Study Overview
Official Title:
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Male infertility affects millions of males worldwide and is rising in prevalence due to social and environmental conditions Asthenozoospermia AZS and oligoasthenozoospermia OA are the major causes of male infertility The diagnosis of male infertility has a negative effect on mens physical and psychological status poses a threat to their social relationships lowers self-esteem and disrupts family harmony At present the treatment of ASZ and OA are all mostly empirical including antioxidants endocrine therapy and anti-infection However there are still limitations due to inefficiencies Linggui Yangyuan paste LGYY a traditional Chinese compound herbal past had been used to treat ASZ and OA for several years at the Xiyuan Hospital of China Academy of Chinese Medical Sciences The investigators designed this program to study the efficacy and safety of LGYY for the treatment of patients with male infertility AZS and OA
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None